CervoMed Inc. (NASDAQ:
CRVO),
a clinical stage company focused on developing treatments
for age-related neurologic disorders (CervoMed or the Company),
today announced positive 32-week data from the
Extension phase of the Phase 2b RewinD-LB
trial showing that oral neflamapimod continued to demonstrate
slowing of disease progression and
demonstrated an effect on a plasma marker of
neurodegeneration in patients with DLB. The disease
progression analyses were featured in two presentations
during the Alzheimer's Association® International Congress 2025
(AAIC) on Sunday, July 27th, 2025.
What is going on with
Posted by skitexas67 on 28th of Jul 2025 at 09:50 am
What is going on with CRVO?
CervoMed Inc.
Posted by EdZ on 28th of Jul 2025 at 10:01 am
CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced positive 32-week data from the Extension phase of the Phase 2b RewinD-LB trial showing that oral neflamapimod continued to demonstrate slowing of disease progression and demonstrated an effect on a plasma marker of neurodegeneration in patients with DLB. The disease progression analyses were featured in two presentations during the Alzheimer's Association® International Congress 2025 (AAIC) on Sunday, July 27th, 2025.
Dementia with Lewy Bodies (so
Posted by steveo on 28th of Jul 2025 at 03:30 pm
Dementia with Lewy Bodies (so is that like Mad Cow)????
Lewy Body Dementia is one
Posted by stoclady on 28th of Jul 2025 at 03:49 pm
Lewy Body Dementia is one of the worse kinds of Dementia to have
Lewy Body Dementia is one
Posted by stoclady on 28th of Jul 2025 at 03:49 pm
Lewy Body Dementia is one of the worse kinds of Dementia to have